Beltsville biopharmaceutical firm NextCure Inc. has raised a $93 million Series B round of equity funding. The financing was led by Asian firms Hillhouse Capital Management and Quan Capital. Michael Yi of Hillhouse Capital Management and Stella Xu of Quan Capital will join NextCure’s board of directors. Additional firms include Bay City Capital, Surveyor Capital, Ping An Ventures, Taiho Ventures LLC, ArrowMark Partners and NS Investment participated. All existing investors — Canaan Partners,…
from https://www.bizjournals.com/baltimore/news/2018/11/13/beltsville-biotech-nextcure-raises-93-million.html?ana=RSS&s=article_search
via http://baltimorecheckbook.tumblr.com/post/180073172737
No comments:
Post a Comment